Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Alcohol Dependence in Convicted Drinking Drivers
NCT01638377Phase 4
Key facts
- Status
- Terminated
- Start
- Aug 2012
- Primary completion
- Mar 2014
- Countries
- 1
- Modality
- Small Molecules
- Drugs
- naltrexone
- Conditions
- alcohol dependence
01
Overview
Phase 4, randomised, double-blind trial of naltrexone in alcohol dependence, sponsored by Center for Addiction and Mental Health. Primary endpoint: Participation rate at 2 years. Started Aug 2012; status: terminated.
02
Design
- Study design
- RandomizedDouble-blind
03
Who it enrols
Convicted drinking drivers with alcohol dependence seeking abstinence, excluding those with other substance use or psychiatric disorders requiring medication.
04
Endpoints
Primary
Participation rate
Secondary
Effect of naltrexone on drinking patterns and drinking related measures
Beyond the preview
Go deeper on NCT01638377.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638377.